Rs964184 (APOA5-A4-C3-A1) Is Related to Elevated Plasma Triglyceride Levels, but Not to an Increased Risk for Vascular Events in Patients with Clinically Manifest Vascular Disease

• Anton P. van de Woestijne,

  Affiliation Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• Yolanda van der Graaf,

  Affiliation Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• Paul I. W. de Bakker,

  Affiliations Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands, Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands, Broad Institute of Harvard and MIT, Cambridge, Massachusetts, United States of America, Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Folkert W. Asselbergs,

  Affiliations Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands, Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands, Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, The Netherlands

  ⨯
• Wilko Spiering,

  Affiliation Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• Frank L. J. Visseren ,

  * E-mail: F.L.J.Visseren@umcutrecht.nl

  Affiliation Department of Vascular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

  ⨯
• for the SMART Study Group

  ¶Membership of the SMART Study Group is provided in the Acknowledgments.

  ⨯